Complete this course and earn 1 Class A credit and 1 Pharmacology credit.
Overview:
Despite decades of research, neuromuscular monitoring and reversal practices are still largely influenced by tradition and local habits rather than evidence-based medicine. As medical advancements continue to evolve, objective monitoring remains the only reliable method for ensuring adequate neuromuscular function.
Quantitative monitoring provides a more precise analysis of human physiology than visual observation, and recent technological improvements in neuromuscular monitoring challenge longstanding practices. With modern techniques, anesthesia care is becoming more precise—ultimately improving patient outcomes.
Based on the following article: The Rise of Quantitative Neuromuscular Monitoring
Moderator:
Nick Obradovich, MS, BS
Editor Coordinator, AANA Journal
Nick is the editor coordinator for the AANA Journal. He has taught college English and journalism for 15 years and has worked for trade magazines and book publishers.
Speaker:
Blakeley F. Ward, MSN, CRNA
A native of Rolling Fork, Mississippi, Blake has over 24 years of combined experience as an intensive care nurse and a CRNA/nurse anesthesiologist at the University of Mississippi Medical Center in Jackson, Mississippi. Mr. Ward is a graduate of both the UMMC School of Nursing as well as the University of Tennessee – Memphis Health Science Center School of Nurse Anesthesia and has served as UMMC's Chief of Anesthesia Quality and Education since 2019. Mr. Ward has been selected as a "Healthcare Hero" and “Top 50 Under 40” by the Mississippi Business Journal, served as President of the Mississippi Board of Nursing, conducted over 90 public speaking events, published 22 articles, given courtroom testimony with cross-examination regarding the practice of Nurse Anesthesiology, practiced as an Intensivist in the UMMC Covid-19 unit, delivered anesthesia in 35 hospitals across Mississippi, Tennessee and central Africa and has spent the last 4 years integrating quantitative neuromuscular monitoring into anesthetic practice.
Key Takeaways:
- Using past techniques, we have consistently been sending 50%+/- of our extubated patients to PACU still paralyzed
- We can accurately measure the depth of paralysis for the first time & it looks very different from what we have been doing our whole career
- Quantitative monitoring changes the way we deliver anesthesia: gasses, narcotics, paralytics, reversals etc
- Ultimately, the only thing that matters is that every patient recovers to 90%… regardless of the method, drug or dose required
- The need for reversal agents, their appropriate dosages, and the patient’s confirmed recovery can only be determined by a quantitative neuromuscular monitor
- The standard of care (90% TOFR) can be achieved in a much more efficient manner than is currently being practiced
Accreditation Information:
The American Association of Nurse Anesthesiology is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
AANA is an approved provider by the California Board of Registered Nursing, CEP #10862.
This webinar has been developed by:
and is sponsored by:
Senzime, based in Uppsala, Sweden, is at the vanguard of a global transformation in perioperative care, led by the advanced, next-generation TetraGraph® monitoring system. This pioneering technology embodies our commitment to enhancing surgical safety, offering clinicians real-time quantitative train-of-four monitoring that ensures optimal patient recovery. The next-generation TetraGraph® stands as a flagship in our suite of solutions, including the ExSpiron® 2Xi, all meticulously engineered to eradicate postoperative complications for over 100 million patients worldwide.
With a robust footprint spanning over 30 countries, Senzime sets new benchmarks in healthcare excellence, harmonizing patient empowerment with clinical precision. As we trade on the Nasdaq Stockholm Main Market (SEZI) and the OTCQX (SNZZF), our trajectory is one of relentless progress, synthesizing stakeholder value with lifesaving innovation.
Discover the next-generation TetraGraph® system's pivotal role in our mission and explore the breadth of our perioperative advancements at senzime.com. Stay connected with our journey towards redefining recovery on LinkedIn.
Link: www.Senzime.com